BioAdaptives, Inc.
BDPT · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.07 | 0.01 | 0.00 | 0.01 |
| FCF Yield | -50.62% | -49.96% | -357.29% | -47.02% |
| EV / EBITDA | -1.20 | -1.37 | -0.79 | -1.07 |
| Quality | ||||
| ROIC | 53.38% | 17.38% | 39.83% | 96.92% |
| Gross Margin | 31.81% | 37.88% | 41.49% | 51.10% |
| Cash Conversion Ratio | 0.28 | 0.31 | 0.25 | 0.15 |
| Growth | ||||
| Revenue 3-Year CAGR | -9.65% | 13.04% | 1.70% | 25.80% |
| Free Cash Flow Growth | -11.50% | 1.53% | -43.24% | -48.43% |
| Safety | ||||
| Net Debt / EBITDA | -0.35 | -0.52 | -0.67 | -0.55 |
| Interest Coverage | -6.55 | -1.41 | -1.46 | -2.33 |
| Efficiency | ||||
| Inventory Turnover | 0.45 | 1.16 | 0.00 | 2.04 |
| Cash Conversion Cycle | 634.82 | 246.78 | -252.01 | 113.23 |